Serina Therapeutics, Inc. (SER:NYSEMKT) closed at $1.79 on October 15, 2026, up 4.68% on the day. The stock trades 66.2% below its 52-week high of $5.29 and 46.7% above its 52-week low of $1.22. Over the past year, it lost 63.4%. Serina Therapeutics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -7.73% | -17.13% | -17.89% | -14.76% | -63.39% |
In 252 trading sessions since October 15, 2025, SER closed higher on 107 days (42%). Its best day was March 19, 2026 (+93.75%) and its worst was March 24, 2026 (-22.86%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 3 times.
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Find more stocks like SER with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.